Invesco Launches New Pharma & Healthcare Equity Fund NFO

Invesco Mutual Fund just launched the Invesco India Pharma and Healthcare Fund. This is an open-ended equity scheme, meaning it continuously issues new shares. The fund will invest in companies across the Pharma, Healthcare, and allied sectors.

• The NFO (New Fund Offer) opens for subscriptions on August 18, 2026.
• It will close on September 1, 2026.
• There is no Entry Load, which is a charge to buy units.
• An Exit Load of 0.50% applies if units are redeemed within three months.
• No exit load is charged after three months.
• Minimum subscription starts at Rs 1,000 per application.

Fund Objective and Management

The main goal of this scheme is to generate long-term capital appreciation, meaning your investment grows over time. It plans to achieve this by investing predominantly in equity and equity-related securities, which are company shares, within the specified sectors.

• The fund’s performance will be measured against the BSE Healthcare TRI, which is its performance standard.
• Aditya Khemani has been appointed as the fund manager.

This new offering provides investors an opportunity to gain exposure to the Pharmaceuticals, Healthcare, and allied sectors. With the NFO opening soon, it reflects Invesco MF’s strategic move to tap into these specific market segments. The fund is structured for long-term growth, aiming for sustained capital appreciation.